Home > Clinical Trials
Check All Search

Saved trials

ACTIVE_NOT_RECRUITING
NCT04294628
Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer
62 Enrollment(s)
6 Study location(s)
INTERVENTIONAL (PHASE1)
Advanced Malignant Solid Neoplasm


Metastatic Malignant Solid Neoplasm


Refractory Malignant Solid Neoplasm


Unresectable Malignant Solid Neoplasm
COMPLETED
NCT03523585
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
608 Enrollment(s)
227 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
ACTIVE_NOT_RECRUITING
NCT06100874
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
28 Enrollment(s)
4 Study location(s)
INTERVENTIONAL (PHASE2)
Her 2 Positive Breast Cancer


Breast Cancer Female


Breast Cancer Metastatic
RECRUITING
NCT07428044
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
14 Enrollment(s)
10 Study location(s)
INTERVENTIONAL (PHASE2)
Non-Small Cell Lung Cancer


Non-small Cell Lung Cancer Stage II


Non-Small Cell Lung Cancer Stage IIIA


Non-Small Cell Lung Cancer Stage IIIB
RECRUITING
NCT07098975
Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)
154 Enrollment(s)
2 Study location(s)
INTERVENTIONAL (PHASE2)
Preeclampsia (PE)


Intrauterine Growth Restriction (IUGR)


Placental Insufficiency
RECRUITING
NCT06058988
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
30 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Brain Cancer


Glioblastoma


Metastatic Cancer


Leptomeningeal Metastasis


Recurrent Glioblastoma
NOT_YET_RECRUITING
NCT07416253
Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer
68 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer